Mississippi AG Sues Manufacturers Over Alleged Insulin Pricing Scheme

Lori Kalani, Bernard Nash
Cozen O'Connor
Contact
LinkedIn
Facebook
X
Send
Embed

Cozen O'Connor

  • Mississippi AG Lynn Fitch sued drug manufacturers and pharmacy benefit managers (“PBMs”) for allegedly working together to manipulate and inflate insulin prices in violation of the Mississippi Consumer Protection Act and state civil conspiracy laws.
  • According to the AG’s Office, the defendant companies raised the reported prices of their respective insulin products by up to 1,000 percent over the course of the last decade through an unlawful conspiracy between the PBMs and manufacturers, in which the manufacturer defendants used the artificially raised prices to pay kick-backs to PBMs through rebates, discounts, credits, and administrative fees. The AG’s Office alleges the defendants raised reported prices within days of each other even though insulin production costs have declined.
  • As previously reported, former Minnesota AG Lori Swanson and former Kentucky AG Andy Beshear filed complaints over similar allegations involving insulin price inflation.
Send Print Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Cozen O'Connor | Attorney Advertising

Written by:

Cozen O'Connor
Cozen O'Connor
Contact
more
less

Cozen O'Connor on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign Up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide